Published in J Immunol on January 01, 1999
Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol (2008) 2.41
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med (2011) 1.97
Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest (2007) 1.75
Biosensors from conjugated polyelectrolyte complexes. Proc Natl Acad Sci U S A (2001) 1.46
Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant (2010) 1.39
Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol (2012) 1.39
Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol (2008) 1.28
Tolerogenic dendritic cells and their role in transplantation. Semin Immunol (2011) 1.26
Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24
Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci (2009) 1.21
The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest (2000) 1.19
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest (2002) 1.12
Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant (2008) 1.02
Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J Leukoc Biol (2012) 1.02
Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol (2013) 1.02
Interleukin-17 promotes early allograft inflammation. Am J Pathol (2010) 0.97
In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS One (2009) 0.97
Recent progress and new perspectives in studying T cell responses to allografts. Am J Transplant (2010) 0.96
Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation (2009) 0.95
Alloimmunity and autoimmunity in chronic rejection. Curr Opin Organ Transplant (2010) 0.93
Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J Immunol (2010) 0.92
Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation. Transpl Int (2007) 0.92
Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin Exp Immunol (2003) 0.90
Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. Am J Transplant (2011) 0.90
Allopeptides and the alloimmune response. Cell Immunol (2007) 0.90
Tolerance of Lung Allografts Achieved in Nonhuman Primates via Mixed Hematopoietic Chimerism. Am J Transplant (2015) 0.88
Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur J Immunol (2009) 0.87
Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice. Am J Transplant (2013) 0.87
Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. Invest Ophthalmol Vis Sci (2009) 0.86
Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice. Blood (2013) 0.86
An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection. Int J Immunogenet (2012) 0.86
Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model. J Immunol (2010) 0.86
The major histocompatibility complex in transplantation. J Transplant (2012) 0.86
Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol (2012) 0.85
Immune surveillance of the maternal/fetal interface: controversies and implications. Trends Endocrinol Metab (2010) 0.85
Antigen location contributes to the pathological features of a transplanted heart graft. Am J Pathol (2004) 0.85
Natural killer cells in rejection and tolerance of solid organ allografts. Curr Opin Organ Transplant (2011) 0.84
Mixed chimerism and split tolerance: mechanisms and clinical correlations. Chimerism (2012) 0.83
Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates. J Immunol (2011) 0.83
Intracellular MHC class II controls regulatory tolerance to allogeneic transplants. J Immunol (2010) 0.83
Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis. J Immunol (2013) 0.82
Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo. Transpl Immunol (2011) 0.82
Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys. Am J Transplant (2015) 0.82
Immunotherapy of tumors with recombinant adenovirus encoding macrophage inflammatory protein 3beta induces tumor-specific immune response in immunocompetent tumor-bearing mice. Acta Pharmacol Sin (2009) 0.81
Direct versus indirect allorecognition pathways: on the right track. Am J Transplant (2009) 0.81
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen. Front Immunol (2016) 0.79
B-cell-dependent memory T cells impede nonmyeloablative mixed chimerism induction in presensitized mice. Am J Transplant (2011) 0.79
Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation. Sci Immunol (2016) 0.79
B Cell Depletion With an Anti-CD20 Antibody Enhances Alloreactive Memory T Cell Responses After Transplantation. Am J Transplant (2015) 0.78
Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications. Hum Immunol (2012) 0.78
Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78
Allorecognition by T Lymphocytes and Allograft Rejection. Front Immunol (2016) 0.77
Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection. Transplantation (2012) 0.77
Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts. J Immunol (2014) 0.77
Antigenicity and immunogenicity of allogeneic retinal transplants. J Clin Invest (2001) 0.77
The road to transplant tolerance is paved with good dendritic cells. Eur J Immunol (2013) 0.76
Both rejection and tolerance of allografts can occur in the absence of secondary lymphoid tissues. J Immunol (2014) 0.76
Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay. PLoS One (2010) 0.76
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus. Am J Transplant (2016) 0.75
Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts. Am J Transplant (2016) 0.75
Role of secondary lymphoid tissues in primary and memory T-cell responses to a transplanted organ. Transplant Rev (Orlando) (2009) 0.75
Cumulative exposure to CD8+ granzyme Bhi T cells is associated with reduced lung function early after lung transplantation. Transplant Proc (2011) 0.75
Persistence of Indirect but Not Direct T Cell Xenoresponses in Baboon Recipients of Pig Cell and Organ Transplants. Am J Transplant (2016) 0.75
Virtual Global Transplant Laboratory Standard Operating Protocol for Donor Alloantigen-specific Interferon-gamma ELISPOT Assay. Transplant Direct (2016) 0.75
Role of Memory T Cells in Allograft Rejection and Tolerance. Front Immunol (2017) 0.75
The CD8 T-cell response during tolerance induction in liver transplantation. Clin Transl Immunology (2016) 0.75
Modeling rejection immunity. Theor Biol Med Model (2012) 0.75
Monitoring alloimmune response in kidney transplantation. J Nephrol (2016) 0.75
Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice. Front Immunol (2017) 0.75
TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement. J Immunol (2017) 0.75
Evolving Approaches in the Identification of Allograft-reactive T and B Cells in Mice and Humans. Transplantation (2017) 0.75
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
Eosinophils are not required for the induction and maintenance of an alloantibody response. Am J Transplant (2013) 2.06
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant (2013) 1.99
Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker. Am J Transplant (2011) 1.71
Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol (1999) 1.66
Strategies to inhibit alloantibody production in alloprimed murine recipients of hematopoietic stem cell grafts. Am J Transplant (2015) 1.39
Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients. Am J Transplant (2008) 1.39
Making sense of polymer-based biosensors. Proc Natl Acad Sci U S A (1999) 1.28
High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation (1998) 1.27
Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am J Transplant (2009) 1.27
Donor kidney volume and outcomes following live donor kidney transplantation. Am J Transplant (2006) 1.26
Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES. J Immunol (1994) 1.21
Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure. Transplantation (1998) 1.10
ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producing peripheral blood lymphocytes in infected humans with and without cirrhosis. Clin Immunol (2001) 1.10
Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts. Am J Transplant (2008) 1.08
Distinct roles for B7-1 and B7-2 determinants during priming of effector CD8+ Tc1 and regulatory CD4+ Th2 cells for contact hypersensitivity. J Immunol (1997) 1.01
Immune cell-derived C3a and C5a costimulate human T cell alloimmunity. Am J Transplant (2013) 0.98
Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization. J Immunol (2000) 0.96
ICOS-Dependent and -independent functions of memory CD4 T cells in allograft rejection. Am J Transplant (2008) 0.94
Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. J Immunol (1998) 0.92
Standardization and cross validation of alloreactive IFNγ ELISPOT assays within the clinical trials in organ transplantation consortium. Am J Transplant (2013) 0.91
Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. Am J Transplant (2011) 0.90
The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients. Am J Transplant (2012) 0.89
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation. Am J Transplant (2013) 0.89
A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen. Transplantation (2001) 0.88
Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen. Transplantation (1999) 0.88
T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest (1998) 0.87
Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice. Am J Transplant (2013) 0.87
CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions. J Immunol (2001) 0.86
Evolving paradigms that determine the fate of an allograft. Am J Transplant (2010) 0.86
B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells. Am J Transplant (2014) 0.86
25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients. Am J Transplant (2010) 0.85
Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling. Am J Transplant (2013) 0.84
Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model. Am J Transplant (2015) 0.84
Indirectly primed CD8+ T cells are a prominent component of the allogeneic T-cell repertoire after skin graft rejection in mice. Transplantation (2001) 0.84
In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition. Transplantation (2001) 0.83
Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection. Am J Transplant (2013) 0.82
CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferon-gamma. Transplantation (2000) 0.82
Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen. J Immunol (2000) 0.82
Induction of T helper 2 immunity to an immunodominant allopeptide. Transplantation (1997) 0.81
Heparin flushes and thrombocytopenia. Ann Intern Med (1986) 0.80
The presentation of self and allogeneic MHC peptides to T lymphocytes. Hum Immunol (1998) 0.79
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation (2001) 0.79
Naturally developing memory T cell xenoreactivity to swine antigens in human peripheral blood lymphocytes. J Immunol (2000) 0.78
Clinical utility of measuring T-cell immunity to CMV in transplant recipients. Am J Transplant (2009) 0.77
Costimulatory blockade-induced allograft survival requires Beclin1. Am J Transplant (2014) 0.76
Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants. Am J Transplant (2015) 0.76
Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed (2001) 0.75
Minimization of immunosuppression in kidney transplantation. The need for immune monitoring. Transplantation (2001) 0.75
Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice. Clin Exp Rheumatol (2001) 0.75
Influence of synthetic peptides, corresponding to fragments of the human alpha-2 interferon molecule, on the proliferation of lymphoblastoid cells in vitro. Growth inhibition and receptor binding. FEBS Lett (1995) 0.75